nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Aims and Scope/Editorial Board/Publishing Details
|
|
|
|
66 |
C |
p. IFC |
artikel |
2 |
Case study on the environmental monitoring for biological manufacturing using Time-lapse Shadow Image Analysis
|
Narutaki, Shoji |
|
|
66 |
C |
p. 1-8 |
artikel |
3 |
Evaluation of a standardised Vi poly-l-lysine ELISA for serology of Vi capsular polysaccharide antibodies
|
Rigsby, Peter |
|
|
66 |
C |
p. 21-29 |
artikel |
4 |
Human challenge trial workshop: Focus on quality requirements for challenge agents, Langen, Germany, October 22, 2019
|
Bekeredjian-Ding, Isabelle |
|
|
66 |
C |
p. 53-61 |
artikel |
5 |
Induction of osteogenic differentiation by demineralized and decellularized bovine extracellular matrix derived hydrogels associated with barium titanate
|
Luciana Aurora Soares do Amaral, Danielle |
|
|
66 |
C |
p. 9-16 |
artikel |
6 |
Potency evaluation of rabies vaccine for human use: The impact of reducing the number of animals per dilution – Part 2
|
Machado, Nathalia S. |
|
|
66 |
C |
p. 30-34 |
artikel |
7 |
Removal of the innocuity test from The International Pharmacopoeia and WHO recommendations for vaccines and biological products
|
Lei, Dianliang |
|
|
66 |
C |
p. 17-20 |
artikel |
8 |
SARS-CoV-2: Virology, epidemiology, immunology and vaccine development
|
Baay, Marc |
|
|
66 |
C |
p. 35-40 |
artikel |
9 |
Third human challenge trial conference, Oxford, United Kingdom, February 6–7, 2020, a meeting report
|
Pollard, Andrew J. |
|
|
66 |
C |
p. 41-52 |
artikel |